Project 3: Mechanisms of Tauopathies Project Leader: Virginia Lee Project Summary/Abstract Frontotemporal lobar degeneration (FTLD) with tau pathology (FTLD-Tau) is a group of clinically heterogeneous neurodegenerative disorders that include progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and Pick's disease (PiD). FTLD-Tau diseases are caused by the accumulation of distinct pathological species or strains of tau (designated PSP-Tau, CBD-Tau, PiD-Tau) and mounting evidence supports a cell-to-cell spread of pathological tau as a major mechanism of disease that could explain the progression of FTLD-Tau since Alzheimer's disease (AD), another major tauopathy demonstrated stereotypical progressive spread of AD tau pathology (AD-Tau) that correlates with progressive dementia. Moreover, Projects 3 and 4 investigators and others modeled the progressive spread of pathological tau in vitro and in vivo and demonstrated that tau pathology propagates from cell-to-cell through intercellular transfer of pathological tau which acts as ?seeds? to recruit soluble tau and corrupt it into pathological tau. Thus, Project 3 proposes to test this ?transmission? hypothesis and to elucidate the mechanisms of progressive cell-to-cell spread of pathological tau in FTLD tauopathies. Since FTLD-Tau disorders are clinically diverse, we hypothesize that misfolded PSP-Tau, CBD-Tau and PiD-Tau represent different tau strains that differ in their conformations and seeding properties. To test this ?strain? hypothesis and to determine the molecular basis for FTLD-Tau strain diversity, we will purify pathological tau from well characterized CBD, PSP and PiD brains obtained from Core D that are deeply phenotypically characterized by Cores B-D and Projects 1 & 2 and use them for in vitro serial amplification experiments to characterize the biochemical and biophysical properties of tau strains. We will extend these studies to include cell biological research conducted on primary neurons from non-transgenic (Tg) and tau Tg mice to determine the molecular mechanisms of spread and toxicity. The effects of genetic factors identified in Project 2 in modifying the transmission of different tau strains will also be evaluated. Finally, Project 3 will also collaborate with Project 4 by providing well-characterized strain specific preparations for in vivo studies to test both the misfolded tau transmission and strain hypothesis.

Public Health Relevance

Project 3: Mechanisms of Tauopathies Project Leader: Virginia Lee Project Narrative Frontotemporal lobar degeneration (FTLD) tauopathies, including progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and Pick's disease (PiD), are clinically heterogeneous diseases that are caused by the accumulation and spread of distinct strains of pathological tau. This project will elucidate the molecular basis of tauopathy strain diversity and the mechanisms of transmission which could provide insights for novel targets development to treat these tauopathies.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG017586-20
Application #
9891012
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2020-03-01
Budget End
2021-02-28
Support Year
20
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Rey, Nolwen L; George, Sonia; Steiner, Jennifer A et al. (2018) Spread of aggregates after olfactory bulb injection of ?-synuclein fibrils is associated with early neuronal loss and is reduced long term. Acta Neuropathol 135:65-83
Irwin, David J; McMillan, Corey T; Xie, Sharon X et al. (2018) Asymmetry of post-mortem neuropathology in behavioural-variant frontotemporal dementia. Brain 141:288-301
Lewczuk, Piotr; Riederer, Peter; O'Bryant, Sid E et al. (2018) Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. World J Biol Psychiatry 19:244-328
Phillips, Jeffrey S; Da Re, Fulvio; Dratch, Laynie et al. (2018) Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease. Neurobiol Aging 63:75-87
Kassubek, Jan; Müller, Hans-Peter; Del Tredici, Kelly et al. (2018) Longitudinal Diffusion Tensor Imaging Resembles Patterns of Pathology Progression in Behavioral Variant Frontotemporal Dementia (bvFTD). Front Aging Neurosci 10:47
Cousins, Katheryn A Q; Ash, Sharon; Grossman, Murray (2018) Production of verbs related to body movement in amyotrophic lateral sclerosis (ALS) and Parkinson's Disease (PD). Cortex 100:127-139
Alcolea, Daniel; Irwin, David J; Illán-Gala, Ignacio et al. (2018) Elevated YKL-40 and low sAPP?:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD. J Neurol Neurosurg Psychiatry :
Zhang, Bin; Yao, Yuemang; Cornec, Anne-Sophie et al. (2018) A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model. Mol Neurodegener 13:59
Porta, Sílvia; Xu, Yan; Restrepo, Clark R et al. (2018) Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat Commun 9:4220
Sanchez-Contreras, Monica Y; Kouri, Naomi; Cook, Casey N et al. (2018) Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci. Mol Neurodegener 13:37

Showing the most recent 10 out of 593 publications